Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The Locations section now includes a large expansion of study sites across multiple countries and regions, listing new sites in the US, Canada, Europe, Asia, Australia, and South America. Several previously listed sites have been removed.
    Difference
    4%
    Check dated 2025-12-19T21:34:37.000Z thumbnail image
  2. Check
    17 days ago
    No Change Detected
  3. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; this maintenance update does not affect the study details, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T17:58:42.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Editorial updates to the Publications section clarify that items are auto-filled from PubMed and may not all pertain to the study; revision tag updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-21T23:00:48.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The government funding status notice on the page has been removed.
    Difference
    0.1%
    Check dated 2025-11-14T16:58:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Two location entries in the Locations list were renamed from 'Santiago de Cali' to 'Cali' for postal codes 76001 and 760042 in Valle del Cauca, Colombia.
    Difference
    0.2%
    Check dated 2025-10-31T06:16:31.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Location naming updated from Bourgogne to Bourgogne-Franche-Comté for Dijon, France (21000); the core location data remains the same.
    Difference
    0.0%
    Check dated 2025-10-09T13:45:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.